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bARK-ctG-protein-coupled receptor kinase 2 (GRK2) levels are elevated in inﬂammation but its role is not
clear yet. Here we show that GRK2 expression is dependent on NFjB transcriptional activity. In mac-
rophages, LPS induces GRK2 accumulation in mitochondria increasing biogenesis. The overexpres-
sion of the carboxy-terminal domain of GRK2 (bARK-ct), known to displace GRK2 from plasma
membranes, induces earlier localization of GRK2 to mitochondria in response to LPS leading to
increased mt-DNA transcription and reduced ROS production and cytokine expression. Our study
shows the relevance of GRK2 subcellular localization in macrophage biology and its potential ther-
apeutic properties in inﬂammation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction might change in different cell types. Indeed, GRK2 is highly ex-Although G protein coupled receptor kinases (GRKs) are classi-
cally considered as the regulators of GPCR signaling through desen-
sitization [1,2], it is evident that their role is more articulated
within the cell. In particular, GRK2 can regulate signaling mediated
by other membrane receptor families, such as tyrosine kinase
receptors for IGF-1, insulin, PDGF or EGF [3,4]. In addition, a grow-
ing number of non receptor substrates have been identiﬁed for
GRK2 [5–7], showing its involvement in the regulation of diverse
cellular functions through the phosphorylation of several sub-
strates or in a phosphorylation-independent manner through pro-
tein–protein interaction [6,8,9].
These novel features of GRK2 allow the kinase to participate in
basic cellular processes such as migration and cell cycle progres-
sion or cardiovascular cell functionality [10–13]. Nevertheless,
we can only partially appreciate the full role of the kinase whichpressed in the immune system being an important regulator of cell
responses during inﬂammation [14]. In particular, mice with GRK2
deletion in cells of myeloid lineage exhibited exaggerated inﬂam-
matory cytokine/chemokine production, and organ injury in re-
sponse to lipopolysaccharide (LPS, a TLR4 ligand) due to
macrophages hyperreaction to stimulants [15]. The link between
GRK2 levels and inﬂammation can be demonstrated both in human
patients [16] and in a number of animal disease models [15,17–
21]. All these evidences suggest a key role of GRK2 in inﬂammation
even if it has not yet been clariﬁed. It is known that inﬂammation
produces mitochondrial damage in host cells, compromising cell
survival and organ function [22]. The damaging effects of inﬂam-
mation on mitochondria are opposed to cellular programs that in-
duce mitochondrial DNA (mtDNA) transcription and replication
and mitochondrial protein synthesis [23,24]. We have recently
demonstrated that GRK2 localizes into mitochondria and regulates
biogenesis and ATP generation [25]. In particular, in other cellular
systems, the overexpression of GRK2 increases ATP cellular content
by enhancing mitochondrial biogenesis and antagonizes ATP loss
after hypoxia/reperfusion. Based on these data, the aim of our
study is to verify whether the ability of GRK2 to regulate mito-
chondrial function plays a role in macrophage activation during
inﬂammation.
Fig. 1. GRK2 levels and effects on inﬂammation. (A) The activation of NFjB and
GRK2 levels were evaluated in cultured macrophages, Raw 264.7, in response to LPS
(20 ng/ml) by western blot. The phosphorylation in Ser 536 and activation of NFjB
occurred early after LPS stimulation and decreased over time. Total NFjB was used
as loading control. LPS induced a time dependent increase of GRK2 protein levels.
Images are representative of 3 independent experiments. (B) To conﬁrm the
inhibition of NFjB activation by overexpression of IjBa, we evaluated IjBa levels
and NFjB phosphorylation and activation by Western blot. The overexpression of
IjBa, induced by transient transfection of IjBa plasmid, is able to inhibit the
activation of NFjB in response to LPS. Images are representative of 3 independent
experiments. (C) GRK2 gene expression was evaluated by Real Time PCR. GRK2
increased in a time dependent manner in response to LPS (20 ng/ml) and its
expression was reduced by IjBa-dependent inhibition of NFjB activity; ⁄P < 0.05 vs
basal, #P < 0.05 vs LPS. Results are the mean of 5 independent experiments and are
presented as mean ± S.E.M.
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Methods are as previously described [25–33]. Extended details
are available in Supplements.
3. Results
3.1. NFjB regulates GRK2 expression during inﬂammation
Given the key role of the transcription factor NFjB in the regu-
lation of inﬂammatory processes, in cultured macrophages, Raw
264.7, we evaluated the activation of NFjB in response to LPS by
western blot. The phosphorylation and activation of NFjB occurred
early after LPS stimulation and decreased over time (Fig. 1A). In
these cells, LPS induced a time dependent increase of GRK2 protein
levels (Fig. 1A). This was in agreement with GRK2 gene expression
which was evaluated by Real Time PCR. Indeed, the expression of
GRK2 increased in a time dependent manner in response to LPS
(Fig. 1C). To assess if this phenomenon was dependent on NFjB
transcriptional activity, we inhibited NFjB activity by overexpress-
ing its known main regulator IjBa (Fig. 1B). Such inhibition was
conﬁrmed by western blot analysis (Fig. 1B) of the phosphorylated
and activated form of NFjB. Real time PCR shows that the overex-
pression of IjBa reduced GRK2 gene expression in response to LPS
(Fig. 1C), suggesting that GRK2 expression is associated with NFjB
activation in response to inﬂammation.
3.2. Subcellular localization of GRK2 in response to LPS stimulation
Since GRK2 levels were increased by LPS stimulation, we ana-
lyzed the subcellular distribution of this kinase. To this aim we
puriﬁed membranes, cytosolic and mitochondrial extracts from
macrophages after LPS stimulation. Western blot analysis of actin,
histone 3 and calnexin levels was performed in puriﬁed extracts to
exclude cross contamination of the different subcellular fractions
(data not shown). Fig. 2 shows that GRK2 is mainly localized in
cytosol both basally and after 1 h of stimulation with LPS
(Fig. 2A). After 3 h of stimulation GRK2 moves to both plasma
membrane (Fig. 2B) and mitochondria (Fig. 2C), decreasing in the
cytosol (Fig. 2A). At 3 and 6 h of stimulation with LPS, GRK2 signif-
icantly accumulated into mitochondria (Fig. 2C). Quantiﬁcations
are shown in Fig. 2D. This suggests a time dependent regulation
of the subcellular localization of GRK2 in mitochondria and a par-
ticular effect of the kinase during sustained inﬂammation. Such
phenomenon is selective for GRK2 since we demonstrated that
GRK5, which is known to be involved in inﬂammatory responses
[34], does not localize in mitochondria (Supplementary Fig. S1).
In order to conﬁrm the increase of GRK2 levels in mitochondria
in response to LPS, we performed a kinase assay in mitochondrial
extracts from macrophages basally and after 6 h of stimulation
with LPS, using rhodopsin as substrate. Rhodopsin phosphorylation
increased in response to LPS respect to control (Supplementary
Fig. S2), thus conﬁrming LPS dependent increase of GRK2 levels
in mitochondria.
3.3. Mitochondrial GRK2 accumulation associates with mitochondrial
biogenesis
Our data conﬁrm the recent demonstration that GRK2 enters
into mitochondria and regulates mitochondrial biogenesis [25]. In-
deed, the overexpression of GRK2 increases mitochondrial biogen-
esis while GRK2 gene deletion exerts the opposite effect [25]. It is
known that inﬂammatory stimuli creates a cycle of oxidative stress
that causes mitochondrial damage and initiates retrograde signals
for the transcriptional activation of mitochondrial biogenesis [24].Therefore, we evaluated mitochondrial biogenesis in macrophages
in response to LPS stimulation focusing on cytochrome b and
NADH dehydrogenase–DNA copy number. In macrophages, LPS
stimulation causes an impairment of mitochondrial biogenesis
which is restored at later time points (12–24 h) (Fig. 2E). Accord-
ingly, manganese superoxide dismutase (Mn-SOD), an anti-oxidant
enzyme, increased in a time dependent manner in response to LPS
(Fig. 2F). Similar results were obtained by analyzing mitochondrial
mass using a speciﬁc ﬂuorescent probe (Mitotracker). Mitochon-
drial mass progressively increased in response to stimulation with
LPS (Fig. 2G).
3.4. bARK-ct induces GRK2 accumulation into mitochondria
Based on previous results, we hypothesized that the late GRK2
accumulation into mitochondria might participate to the rescue
Fig. 2. GRK2 levels and its subcellular localization during inﬂammation. (A–D) Cultured macrophages were stimulated with LPS and GRK2 expression was analyzed in
membrane, cytosolic and mitochondrial extracts by Western blot. GRK2 is mainly localized in cytosol both basally and after 1 h of stimulation with LPS (20 ng/ml) (A). After
3 h of stimulation GRK2 moves to both plasma membrane (B) and mitochondria (C), decreasing in the citosol (A). At 3 and 6 h of stimulation with LPS, GRK2 signiﬁcantly
accumulated into mitochondria (C). Actin, Gai and VDAC-1 were used as loading controls for cytosolic, membrane and mitochondrial samples, respectively. Images are
representative of 5 independent experiments. and the media of quantiﬁcations are shown in bar graph (D) ⁄P < 0.05 vs basal. (E) Mitochondrial biogenesis in macrophages was
evaluated by Real Time PCR. Cytochrome b and NADH dehydrogenase–DNA copy number were evaluated in response to LPS (20 ng/ml). Mitochondrial biogenesis was
impaired by LPS stimulation and was restored at later time points. ⁄P < 0.05 vs basal. Results are the mean of 5 independent experiments and are presented as mean ± S.E.M. (F
and G) In agreement with results of mitochondrial biogenesis, mitochondrial mass, evaluated by western blot using the antibody against Mn-SOD (F) and ﬂuorescence
analysis using the ﬂuorescent probe Mitotracker (G), analyzed in microplate reader, were increased in response to LPS; ⁄P < 0.05 vs basal. Results are the mean of 3
independent experiments.
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sought to enrich GRK2 in mitochondria. It has been previously
demonstrated that GRK2 can be displaced from one cellular com-
partment to another using the overexpression of a truncated mu-
tant of GRK2 reproducing its carboxy-terminal domain (bARK-ct)
[35]. Thus, we evaluated whether bARK-ct could move GRK2 out
of the cell membrane towards mitochondria. To this aim, we over-
expressed bARK-ct in macrophages by means of adenoviral medi-
ated gene transfer (AdbARK-ct) and evaluated GRK2 levels on
plasma membrane, cytosolic and mitochondrial extracts. Fig. 3
shows that bARK-ct expression led to GRK2 moving from plasmamembrane (Fig. 3A) toward mitochondria (Fig. 3B) and this phe-
nomenon was increased in response to LPS (Fig. 3A and B). Cyto-
solic GRK2 levels changed accordingly (Fig. 3C). Such results
were quantiﬁed and showed in bar graph (Fig. 3). These data sug-
gest that the displacement of GRK2 from plasma membrane leads
to a different subcellular localization of this kinase.
3.5. Mitochondrial GRK2 regulates mitochondrial biogenesis
We then evaluated the effect of bARK-ct dependent mitochon-
drial localization of GRK2 in inﬂammation. In particular, we
Fig. 3. bARK-ct induces GRK2 accumulation into mitochondria. (A–C) bARK-ct was expressed in macrophages by means of adenoviral gene transfer (AdbARK-ct) and GRK2
levels were evaluated on plasma membrane and mitochondrial extracts by western blot. bARK-ct reduced GRK2 expression on plasma membrane (A) and increased GRK2
localization into mitochondria both in basal condition and after stimulation with LPS (20 ng/ml) (B). Gai and VDAC were used as loading controls for plasma membrane and
mitochondrial extracts, respectively. bARK-ct was visualized using the speciﬁc antibody against the carboxy-terminal domain of GRK2. Cytosolic localization of GRK2 is
shown in panel C. Actin was used as loading control. Images are representative of 3 independent experiments and the media of quantiﬁcations are shown in bar graph
⁄P < 0.05 vs basal. (D and E)Mitochondrial biogenesis was evaluated by Real time PCR. Cytochrome b (C) and NADH dehydrogenase (D) DNA copy numbers were analyzed in
response to LPS (20 ng/ml) in presence or absence of bARK-ct. Mitochondrial DNA copy numbers increased after 12 and 24 h of stimulation with LPS and bARK-ct anticipated
such increase at 1 and 3 h after stimulation; ⁄P < 0.05 vs basal, #P < 0.05 vs LPS. Results are the mean of 5 independent experiments and are presented as mean ± S.E.M.
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to LPS in presence or absence of bARK-ct. Mitochondrial DNA copy
number of cytochrome b (Fig. 3C) and NADH dehydrogenase
(Fig. 3D) were both increased after 12 and 24 h of stimulation with
LPS and bARK-ct anticipated such increase at 1 and 3 h after stim-
ulation (Fig. 3C and D).
3.6. Mitochondrial GRK2 inhibits ROS production and inﬂammatory
cytokines expression
As an alternative to demonstrate the positive effect of GRK2, we
analyzed reactive oxygen species (ROS) production in
macrophages. To this aim, RAW264.7 were treated with DCFH for
15 min and then stimulated with LPS. ROS production inLPS-activated macrophages progressively increased over time
(Fig. 4A). The treatment with bARK-ct reduced ROS production ba-
sally and in response to LPS, with a decline starting from the 6th
hour of stimulation (Fig. 4A). The inhibition of ROS production in-
duced by bARK-ct was associated to a reduction of cytokines pro-
duction. Indeed, bARK-ct inhibited IL-1b (Fig. 4B), IL-10 (Fig. 4C)
and MCP-1 (Fig. 4D) gene expression in response to LPS, evaluated
by Real Time PCR. All these data suggest that the mitochondrial
localization of GRK2 is key for inhibition of inﬂammation.
3.7. GRK2 silencing enhances inﬂammatory responses
So far our data do not allow to distinguish if the beneﬁcial ef-
fects of bARK-ct were due to GRK2 accumulation into mitochondria
Fig. 4. Mitochondrial GRK2 inhibits ROS production and inﬂammatory cytokines expression. (A–D) RAW264.7 were treated with DCFH for 15 min and then stimulated with
LPS (20 ng/ml) for different time points. ROS production in LPS-activated macrophages was progressively increased with time (A). bARK-ct reduced ROS production both
basally and after LPS stimulation (A). The inhibition of ROS production by bARK-ct was associated to a reduction of cytokines gene expression (B–D). Indeed, bARK-ct inhibited
IL-1b (B), IL-10 (C) and MCP-1 (D) gene expression, evaluated by Real Time PCR, in response to LPS; ⁄P < 0.05 vs basal,#P < 0.05 vs LPS. Results are the mean of 5 independent
experiments and are presented as mean ± S.E.M.
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induced GRK2 gene silencing by means of speciﬁc siRNA. Gene
silencing was evaluated by Western blot analysis. Transfection of
the speciﬁc siRNA induces a signiﬁcant reduction of GRK2 expres-
sion respect to the transfection of Scramble (Fig. 5A). Fig. 5 shows
that the silencing of GRK2 was inhibitory per se on mitochondrial
biogenesis (Fig. 5B), increased ROS production (Fig. 5C) and in-
creased cytokines gene expression (Fig. 5D) in response to LPS
stimulation. These ﬁndings conﬁrm the key role of GRK2 in inﬂam-
matory settings. Interestingly, none of these phenotypes could be
restored by the concomitant overexpression of bARK-ct (Fig. 5B–
D), thus suggesting that the effects of bARK-ct in response to
inﬂammatory stimuli are not independent from GRK2 but rather
depends on the ability of bARK-ct to regulate GRK2 subcellular
localization. These data conﬁrmed the protective role of GRK2 in
inﬂammation due to its ability to restore mitochondrial biogenesis.
4. Discussion
G-protein coupled receptor kinase 2 (GRK2) is a member of a ki-
nase family originally known for its role in the phosphorylation
and desensitization of G-protein coupled receptors [1,2]. In the last
decade new functions for this kinase have been evidenced in sev-
eral conditions (cardiovascular, inﬂammatory diseases or cancer)
characterized by impaired levels of GRK2 [10,12,13,36]. These ﬁnd-
ings suggest that GRK2 could be a potential interesting diagnostic
marker and therapeutic target for several conditions. This pleiotro-
pism of GRK2 is possibly due to some emerging properties of the
kinase as well as to yet unexplored features. We focused on the re-
cently discovered ability of the kinase to localize in mitochondriaand, in particular, the effect of mitochondrial localization of
GRK2 in inﬂammation. It is already known that GRK2 levels in-
crease in inﬂammation. Our study though provides a series of sig-
niﬁcant advancements in knowledge. First of all we demonstrate
that GRK2 regulation in macrophages is dependent on NFjB tran-
scriptional activity. This result is in agreement with previous re-
ports which show a similar NFjB dependent expression also for
other GPCR kinases [37]. The different role of GRK2 in the regula-
tion of intracellular signaling depends on speciﬁc stimuli, cell type
or physiological context [12], but also the subcellular localization is
a ﬁne predictor of its function. Indeed, GRK2 regulates GPCR activa-
tion when it is localized on plasma membrane [38,39]; it regulates
intracellular signaling in a phosphorylation-dependent or -inde-
pendent manner when it is localized in the cytosol [40]; GRK2 reg-
ulates mitochondrial biogenesis when it accumulates into
mitochondria [25]. Thus, GRK2 function is strictly correlated to
its subcellular localization, as it was previously demonstrated also
for other kinases [26,41,42]. The second major ﬁnding is that GRK2
accumulates into mitochondria in response to inﬂammatory stim-
uli in a time dependent fashion activating mitochondrial biogene-
sis and this phenomenon is selective for GRK2 since GRK5, also
known to be involved in inﬂammation, does not localize in mito-
chondria both basally and after LPS stimulation. Giving the emerg-
ing key role of GRK2 in mitochondria which is able to enhance ATP
accumulation, mitochondrial mass and consequent resistance to
ischemic insult, the possibility to regulate its subcellular localiza-
tion represents an efﬁcient therapeutic strategy for all those condi-
tions in which cell is under stress. Here we use bARK-ct as
regulator of GRK2 displacement within the cell during inﬂamma-
tion. Indeed, an important evidence of this study is that the
Fig. 5. GRK2 silencing enhances inﬂammatory responses. (A–D) GRK2 gene silencing was induced by transfection of the speciﬁc siRNA. Western blot analysis was performed
to evaluate the rate of reduction of GRK2. The loss of GRK2 reduced mitochondrial biogenesis (B), increased ROS production (C) and increased cytokines gene expression (D) in
response to LPS stimulation (20 ng/ml) and bARK-ct treatment is not able to restore these phenotypes when GRK2 is silenced. Results are the mean of 5 independent
experiments and are presented as mean ± S.E.M.; ⁄P < 0.05 vs basal, #P < 0.05 vs LPS.
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mitochondria in response to LPS-induced inﬂammation. Stimula-
tion of the innate immune system by activation of toll-like recep-
tors (TLR) generates pro-inﬂammatory mediators, such as tumor
necrosis factor-a (TNF-a) and interleukin-1b (IL-1b), necessary
for optimal host defense, but which also contribute to mitochon-
drial damage through oxidative stress and other mechanisms
[24]. To protect its energy supply, host cells sense mitochondrial
damage and initiate mitochondrial biogenesis under the control
of an inducible transcriptional program that also activates antiox-
idant and anti-inﬂammatory gene expression [24]. Accordingly to
our previous observations [25], here we demonstrated that GRK2
moves to mitochondria to exert an anti-inﬂammatory effect in
macrophages by restoring mitochondrial function. bARK-ct amelio-
rates this effect because it anticipates GRK2 localization into mito-
chondria leading to an increase of mt-DNA transcription, a
reduction of ROS production and inﬂammatory cytokines expres-
sion in response to LPS stimulation. A third important ﬁnding of
our work is that the positive effect of bARK-ct treatment cannot
be limited to the reduction of GRK2 dependent desensitization.
The key role of bARK-ct-induced inhibition of GRK2 in cardiovascu-
lar diseases is known and bARK-ct is often proposed as promising
gene therapy strategy to increase contractility and function of thefailing heart [43]. Here we show that the role of bARK-ct is not lim-
ited to the displacement of GRK2 from plasma membrane and con-
sequently up-regulation of GPCR signaling. Indeed, besides the loss
of GPCRs desensitization, bARK-ct accumulates GRK2 in different
cellular compartments. This ﬁnding is in agreement with recent lit-
erature suggesting that bARK-ct ameliorates cardiac metabolism
and cardiac contractility in experimental myocardial infarction
[44]. However, our data appear to be in contrast with those re-
ported very recently by Chen et al. [45]. Indeed, these Authors
show that bARK-ct prevents stress-induced translocation of GRK2
to mitochondria in neonatal rat ventricular myocytes and de-
creases myocytes apoptosis. Differences in the timing and the
experimental model might explain these opposing results; GRK2
could have different effects depending on speciﬁc cell type and
stimulus, as it happens for other proteins: NFjB for instance has
a pro-apoptotic function in cardiac cells and is anti-apoptotic in
other cell types [26,46]. Furthermore, our data are in agreement
with Patial and co-authors which demonstrated that GRK2 deletion
in myeloid cells induces inﬂammation in vivo [15]. Altogether,
these ﬁndings conﬁrm the key role of GRK2 in the regulation of
inﬂammation. A possible limitation of this study could be the
experimental model, the RAW264.7 cells. These cells are macro-
phage like cell line which maintains many of the properties of
D. Sorriento et al. / FEBS Letters 587 (2013) 3487–3494 3493macrophages (no production, phagocytosis, extreme sensitivity to
TLR agonists and motility). However, differences in response of this
cell line compared to naive macrophages, might occur and should
be taken into account.
In conclusion, our study clariﬁes the involvement of GRK2 in
inﬂammatory settings and underlines the importance of the regu-
lation of protein subcellular localization to modulate intracellular
signaling both in physiological and pathological contexts. In partic-
ular, the regulation of GRK2 mitochondrial translocation could be a
potential therapeutic target for inﬂammatory diseases to restore
impaired mitochondrial function and oxidative stress.
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